ALKERMES | ALKS - 販売および管理費





販売および管理費 変化する 日付
AbbVie USD 3.63B 54M 2026-06
Acadia Pharmaceuticals USD 160.79M 14.06M 2026-03
ALKERMES USD 196.64M 67.96M 2026-06
Amgen USD 1.58B 354M 2026-03
Biogen USD 709.7M 155.4M 2026-06
BioMarin Pharmaceutical USD 258.28M 63.92M 2026-03
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Coherus Biosciences USD 15M 6.26M 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
Heron Therapeutics USD 23.74M 605K 2025-12
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
J&J USD 6.42B 381M 2026-06
Malin Corporation EUR 1.1M 400K 2024-12
Merck USD 2.67B 180M 2026-03
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Neurocrine Biosciences USD 383.1M 64.6M 2026-06
Otsuka Holdings JPY 274.44B 14.95B 2026-06
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 2.92B 1.16B 2026-03
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Vertex Pharmaceuticals USD 493.7M 6.7M 2026-03